Streetbeat News

Regulatory

AMZN

INTC

TRFK

TSM

WISE

Intel Corp (NASDAQ:INTC) stock rose after CEO Pat Gelsinger announced a restructuring plan, including a multi-billion-dollar chipmaking deal with Amazon and a U.S. semiconductor grant. Intel plans to convert its foundry business into an independent unit and explore a spinoff. The company also secured $3 billion in funding under the CHIPS Act and will produce AI chips for Amazon. Intel's stock has dropped 45% in the past year due to challenges in capitalizing on AI trends.

Portfolio Pulse from Anusuya Lahiri

September 17, 2024 | 12:47 pm

CENN

Cenntro Inc. has introduced the Logistar 450, a new electric commercial vehicle model, for the U.S. and global markets. The LS450 has received CARB certification in California and a Certificate of Conformity from the U.S. EPA.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:43 pm

TSLA

Former Tesla executive Rohan Patel suggests that Elon Musk's endorsement of Donald Trump may not significantly impact the upcoming presidential elections. Musk's previous endorsement of Andrew Yang did not have a major effect. The election results could influence Tesla, especially given Trump's criticism of EV subsidies. Musk believes that removing EV subsidies could benefit Tesla in the long term.

Portfolio Pulse from Anan Ashraf

September 17, 2024 | 12:36 pm

MBOT

Microbot Medical has achieved 50% enrollment in its pivotal clinical trial for the LIBERTY Endovascular Robotic Surgical System. The company anticipates full enrollment and a 510(k) FDA submission by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:34 pm

DDD

3D Systems has received FDA clearance for its Monolithic Jetted Denture solution, a significant milestone in the dental industry. This approval allows the company to market its innovative denture solution in the United States, potentially boosting its market presence and revenue.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:31 pm

BTCUSD

ETHUSD

A trader named BasedBoi has placed a $200,000 bet on the Federal Reserve keeping interest rates unchanged at the upcoming meeting, despite market expectations of a rate cut. This bet contrasts with the CME Fedwatch tool's 100% probability of a rate cut. The decision has significant implications for the broader market, including digital assets like Bitcoin and Ethereum.

Portfolio Pulse from Murtuza Merchant

September 17, 2024 | 12:21 pm

AIMD

Ainos is set to begin a clinical study in Taiwan for VELDONA as a treatment for oral warts in HIV-positive patients, following its FDA orphan drug designation. The study will start at National Taiwan University Hospital in November 2024.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:11 pm

MDAI

Spectral AI plans to submit a De Novo request for its DeepView AI-Burn device to be classified as a Class II medical device by Q2 2025.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:05 pm

GLMD

INTC

SES

Intel shares rise 11% following a strategic collaboration with AWS to boost US chip manufacturing. SES AI shares surge 57% after announcing a collaboration with NVIDIA, Crusoe, and Supermicro on AI for scientific initiatives. Galmed Pharmaceuticals regains Nasdaq compliance.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:04 pm

BGNE

BeiGene announced that the Israeli Ministry of Health has approved TEVIMBRA (Tislelizumab) for use as a monotherapy in adult patients with unresectable or metastatic OESCC who have undergone prior systemic chemotherapy.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:46 am